# Syros Pharmaceuticals, Inc.: funding, H-1B (2024)

Registers read on November 19, 2026.

Syros Pharmaceuticals, Inc. (Massachusetts) appears in 2 public registers SpecStream reads: 7 Form D filings and 5 certified H-1B and PERM cases; the newest record is dated September 29, 2024, and the registers were read on November 19, 2026.

SpecStream is the live web data engine for teams and agents. This page joins the public registers SpecStream already reads for one company.

- Registers: 2
- Newest record: September 29, 2024
- State: Massachusetts

## Form D filings (SEC)

7 Form D filings, newest September 21, 2022.

| Record | Date | Detail | Source |
| --- | --- | --- | --- |
| [Form D](https://specstream.ai/data/form-d/company/syros-pharmaceuticals-inc-1556263) | September 21, 2022 | $129.8 million sold of $129.8 million offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/1556263/000155626322000001/0001556263-22-000001-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/syros-pharmaceuticals-inc-1556263) | December 17, 2020 | $90.5 million sold of $121.6 million offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/1556263/000155626320000001/0001556263-20-000001-index.htm) |
| [Form D amendment](https://specstream.ai/data/form-d/company/syros-pharmaceuticals-inc-1556263) | February 9, 2018 | $11.4 million sold of $11.4 million offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/1556263/000155626318000002/0001556263-18-000002-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/syros-pharmaceuticals-inc-1556263) | January 17, 2018 | $10 million sold of $10 million offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/1556263/000155626318000001/0001556263-18-000001-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/syros-pharmaceuticals-inc-1556263) | October 24, 2014 | $53.1 million sold of $53.1 million offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/1556263/000155626314000001/0001556263-14-000001-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/syros-pharmaceuticals-inc-1556263) | April 22, 2013 | $10 million sold of $12 million offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/1556263/000155626313000002/0001556263-13-000002-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/syros-pharmaceuticals-inc-1556263) | August 22, 2012 | $1.2 million sold of $1.2 million offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/1556263/000155626312000001/0001556263-12-000001-index.htm) |

- [Syros Pharmaceuticals, Inc.](https://specstream.ai/data/form-d/company/syros-pharmaceuticals-inc-1556263)
- [SEC EDGAR filings](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1556263&type=D)

## H-1B and PERM certifications (Department of Labor)

5 certified H-1B and PERM cases, newest September 29, 2024.

- EIN: 45-3772460

| Record | Date | Detail | Source |
| --- | --- | --- | --- |
| [Senior Scientist, Analytical Development](https://specstream.ai/data/hiring/employer/syros-pharmaceuticals-inc-453772460) | September 29, 2024 | PERM, 1 case, $151.2 thousand offered | [dol.gov](https://www.dol.gov/sites/dolgov/files/ETA/oflc/pdfs/PERM_Disclosure_Data_New_Form_FY2024_Q4.xlsx) |
| [Associate Director of Drug Safety](https://specstream.ai/data/hiring/employer/syros-pharmaceuticals-inc-453772460) | July 1, 2024 | H-1B, 1 case, $200 thousand offered | [dol.gov](https://www.dol.gov/sites/dolgov/files/ETA/oflc/pdfs/LCA_Disclosure_Data_FY2024_Q4.xlsx) |
| [Senior Manager, Financial Planning & Analysis](https://specstream.ai/data/hiring/employer/syros-pharmaceuticals-inc-453772460) | July 1, 2024 | H-1B, 1 case, $167.4 thousand offered | [dol.gov](https://www.dol.gov/sites/dolgov/files/ETA/oflc/pdfs/LCA_Disclosure_Data_FY2024_Q4.xlsx) |
| [SVP Global Regulatory Affairs & Quality & Op Excellence](https://specstream.ai/data/hiring/employer/syros-pharmaceuticals-inc-453772460) | March 20, 2024 | H-1B, 1 case, $432.6 thousand offered | [dol.gov](https://www.dol.gov/sites/dolgov/files/ETA/oflc/pdfs/LCA_Disclosure_Data_FY2024_Q2.xlsx) |
| [Contracts Manager](https://specstream.ai/data/hiring/employer/syros-pharmaceuticals-inc-453772460) | March 13, 2024 | PERM, 1 case, $120 thousand offered | [dol.gov](https://www.dol.gov/sites/dolgov/files/ETA/oflc/pdfs/PERM_Disclosure_Data_FY2024_Q4.xlsx) |

- [Syros Pharmaceuticals, Inc.](https://specstream.ai/data/hiring/employer/syros-pharmaceuticals-inc-453772460)

## How these records were matched

Records are joined when they carry the same SEC CIK, EIN or UEI, or when their legal names match word for word, legal form aside, at an address in the same state (Massachusetts), and no register gives a second identifier, a second headquarters or a second filer of that name. Each record links to its own page and to the agency that published it.

Source: the registers named in each section. Public records of US federal and state agencies.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Massachusetts

- [Pharmaceutical companies in Massachusetts, United States](https://specstream.ai/data/businesses/pharmaceutical-companies/massachusetts-united-states)
- [Inspection companies in Massachusetts, United States](https://specstream.ai/data/businesses/inspection-companies/massachusetts-united-states)
- [Oral and maxillofacial surgery practices in Massachusetts, United States](https://specstream.ai/data/businesses/oral-and-maxillofacial-surgery-practices/massachusetts-united-states)
- [Siding contractors in Massachusetts, United States](https://specstream.ai/data/businesses/siding-contractors/massachusetts-united-states)
- [Appraisers in Massachusetts, United States](https://specstream.ai/data/businesses/appraisers/massachusetts-united-states)
- [Commercial printers in Massachusetts, United States](https://specstream.ai/data/businesses/commercial-printers/massachusetts-united-states)
